Evidence map›Paper›PMID 39415169›Full record

ArticleJournal of ovarian research2024

Melatonin increases superoxide dismutase 2 (SOD2) levels and improves rat ovarian graft function after transplantation.

Karla Krislane Alves Costa Monteiro, Luciana Lamarão Damous, Marcos Eiji Shiroma, Lara Termini, José Cipolla-Neto, Ricardo Dos Santos Simões, Rinaldo Florencio da Silva, José Antonio Turri, Edmund C Baracat, Jose Maria Soares-Junior

Abstract read
In one paragraph

Article in Journal of ovarian research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karla Krislane Alves Costa MonteiroDepartment of Obstetrics and Gynecology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 05403-010, Brazil. karlacos06@gmail.com.
Luciana Lamarão DamousDepartment of Obstetrics and Gynecology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 05403-010, Brazil.
Marcos Eiji ShiromaDepartment of Obstetrics and Gynecology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 05403-010, Brazil.
Lara TerminiCancer Innovation Laboratory, Center for Translational Research in Oncology (CTO), Cancer Institute of the State of São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo, São Paulo, 01246-000, Brazil.
José Cipolla-NetoInstitute of Biomedical Sciences (IBC-I), Neurobiology Laboratory, Physiology Department, Universidade de São Paulo, São Paulo, 05508-000, Brazil.
Ricardo Dos Santos SimõesDepartment of Obstetrics and Gynecology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 05403-010, Brazil.
Rinaldo Florencio da SilvaDepartment of Morphology and Genetics/Discipline of Histology and Structural Biology, Escola Paulista de Medicina - Universidade Federal de São Paulo (EPM- UNIFESP), São Paulo, 04023-062, Brazil.
José Antonio TurriDepartment of Obstetrics and Gynecology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 05403-010, Brazil.
Edmund C BaracatDepartment of Obstetrics and Gynecology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 05403-010, Brazil.
Jose Maria Soares-JuniorDepartment of Obstetrics and Gynecology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 05403-010, Brazil.

Funding

"Fundação de Amparo à Pesquisa do Estado de São Paulo FAPESP 2018/24224-9"Fundação de Amparo à Pesquisa do Estado de São Paulo FAPESP " 2019/24327-5
6 · The paper itself

Abstract

backgroundOvarian cryopreservation is a promising technique despite being hindered by damage from freezing and thawing. Melatonin can mitigate this outcome.

objectiveThis study aimed to evaluate the effect of melatonin on the follicular dynamics of ovarian tissue in a cryopreserved cell culture.

methodsThree-month-old adult female Wistar rats (n = 24) weighing approximately 250 g were oophorectomized and divided into two groups (n = 12): the control group (CG) and the melatonin group (MG). In the CG, slow cryopreservation was performed according to the standard protocol with Medium M2 and dimethyl sulfoxide (DMSO). In MG, melatonin diluted in ethyl alcohol vehicle at a concentration of 0.1 μm was added to the culture medium. In both groups, the ovaries were cryopreserved by slow freezing and kept in liquid nitrogen for 24 h. Subsequently, after thawing, the ovaries were reimplanted in the retroperitoneum, one on each side of the great vessels (inferior vena cava and aorta). After 30 days, the animals were euthanized during the diestrus phase; then, the grafts were removed and processed for histomorphometric and immunohistochemical analyses, whereas the blood was subjected to biochemical analysis. Student's t test was used to assess the difference between the groups.

resultsThe FSH levels in MG (83.79 ± 32.37) were lower than those in CG (120.52 ± 36.59), p = 0.03. The FSH/AMH ratios were also lower in MG (3.53 ± 1.13) than in CG (6.52 ± 2.85), p = 0.001. The SOD2 immunoexpression was higher in MG than in CG regarding all parameters except for the degenerated follicles (follicular cells and internal thecal cells): CG (16.80 ± 4.80 [13.36-20.24]) and MG (14.91 ± 4.04 [12.01-17.79]) p = 0.351. Statistically, the difference in intact follicles (theca + interstitium) between CG (6.60 ± 2.59 [4.75-8.45]) and MG (9.31 ± 3.09 [7.09-11.51]) was significant (p = 0.049), with a small difference in the expression of regular antral follicles.

conclusionsMelatonin can improve the quality of cryopreserved tissues, as evidenced in this study, and the evaluation of cryopreserved ovarian grafts, as shown in the melatonin group with better hormonal parameters and greater immunohistochemical expression of the SOD2 antioxidant. Thus, damage is reduced during cryopreservation and transplantation is improved.

Indexed as

CryopreservationMelatoninOvaryRats, WistarSuperoxide DismutaseAnimalsFemaleOvarian FollicleRatsSuperoxide Dismutase 2MelatoninSuperoxide DismutaseSuperoxide Dismutase 2CryopreservationFertility preservationMelatoninOvarian transplantationOvaryRatsTissue preservationTransplantation

Identifiers

PMID39415169
PMCPMC11481372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.